1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9404, NCCTG-947251, SWOG-9340, RTOG-94-04
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCOG-6G852, NCI-T86-0222D, T86-0222
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: RTOG-8905, RTOG-89-05
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: NCI-D82-004-688, BTRC-8222
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MICH-T87-0015, NCI-T87-0015O, T87-0015
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: MDA-DM-93088, NCI-T93-0118D, T93-0118
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCC-RAD-9305, NCI-T96-0071, T96-0071
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: RUSH-AML-9754, ALZA-RUSH-AML-9754, NCI-V98-1445, NCT00003405
|
|
9.
|
Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: UCHSC-98374, NCI-T98-0058, NCT00003832, T98-0058
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: NCOG-6G821, NCOG-6G-82-1
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 to 75
Sponsor: NCI
Protocol IDs: MDA-DM-94003, NCI-T94-0009D, T94-0009
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-80-C-143, NCI-T83-0981N
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MICH-125-36-2971, NCI-T83-1201H, T83-1201
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 16
Sponsor: NCI
Protocol IDs: MICH-PCPP12-86, NCI-T86-0253O, T86-0253
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MICH-M1184, NCI-T87-0227O, T87-0227
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-9141, NCI-T91-0275D, T91-0275
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BTRC-9101, NCI-T91-0228H, T91-0228
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-9210, NCI-T91-0232D, T91-0232
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-9127, NCI-T92-0034D, T92-0034
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 16
Sponsor: NCI
Protocol IDs: MDA-ID-92005, NCI-T92-0053D, T92-0053
|
|
21.
|
Phase: No phase specified
Type: Treatment
Status: Completed
Age: under 71
Sponsor: NCI
Protocol IDs: EST-1374, RTOG-7401
|
